Literature DB >> 19028409

Herpes zoster and meningitis resulting from reactivation of varicella vaccine virus in an immunocompetent child.

Sujit Iyer1, Manoj K Mittal, Richard L Hodinka.   

Abstract

Herpes zoster complicated by meningitis has been mainly reported in immunocompromised patients after reactivation of wild-type varicella-zoster virus. We present one of the first cases of aseptic meningitis after herpes zoster caused by reactivation of vaccine-type varicella-zoster virus in an immunocompetent child. We also highlight the increasing role of both wild-type and vaccine strains of varicella-zoster virus as a cause of viral meningoencephalitis and the use of appropriate laboratory tools to rapidly and accurately identify the virus in order to provide prompt patient care and management.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19028409     DOI: 10.1016/j.annemergmed.2008.10.023

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  17 in total

1.  Differentiated neuroblastoma cells provide a highly efficient model for studies of productive varicella-zoster virus infection of neuronal cells.

Authors:  Jenna Christensen; Megan Steain; Barry Slobedman; Allison Abendroth
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  A Toddler With Rash, Encephalopathy, and Hemolytic Anemia.

Authors:  Christiana Smith; Cullen Dutmer; D Scott Schmid; Megan K Dishop; William J Bellini; Erwin W Gelfand; Edwin J Asturias
Journal:  J Pediatric Infect Dis Soc       Date:  2015-05-28       Impact factor: 3.164

3.  Novel genetic variation identified at fixed loci in ORF62 of the Oka varicella vaccine and in a case of vaccine-associated herpes zoster.

Authors:  Mark L Quinlivan; Nancy J Jensen; Kay W Radford; D Scott Schmid
Journal:  J Clin Microbiol       Date:  2012-02-29       Impact factor: 5.948

4.  Vaccine Oka Varicella Meningitis in Two Adolescents.

Authors:  Whitney E Harrington; Sayonara Mató; Lauri Burroughs; Paul A Carpenter; Anne Gershon; D Scott Schmid; Janet A Englund
Journal:  Pediatrics       Date:  2019-12       Impact factor: 7.124

5.  Varicella zoster disease of the central nervous system: epidemiological, clinical, and laboratory features 10 years after the introduction of the varicella vaccine.

Authors:  Barbara A Pahud; Carol A Glaser; Cornelia L Dekker; Ann M Arvin; D Scott Schmid
Journal:  J Infect Dis       Date:  2010-12-21       Impact factor: 5.226

6.  Perspectives on vaccines against varicella-zoster virus infections.

Authors:  Anne A Gershon; Michael D Gershon
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

7.  A spread-deficient cytomegalovirus for assessment of first-target cells in vaccination.

Authors:  Christian Andreas Mohr; Jurica Arapovic; Hermine Mühlbach; Marc Panzer; Annelies Weyn; Lars Dölken; Astrid Krmpotic; David Voehringer; Zsolt Ruzsics; Ulrich Koszinowski; Torsten Sacher
Journal:  J Virol       Date:  2010-05-12       Impact factor: 5.103

Review 8.  Pathogenesis and current approaches to control of varicella-zoster virus infections.

Authors:  Anne A Gershon; Michael D Gershon
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

Review 9.  Neurovirulence of varicella and the live attenuated varicella vaccine virus.

Authors:  Corey Horien; Charles Grose
Journal:  Semin Pediatr Neurol       Date:  2012-09       Impact factor: 1.636

Review 10.  Varicella Zoster Virus: A Common Cause of Stroke in Children and Adults.

Authors:  Catherine Amlie-Lefond; Don Gilden
Journal:  J Stroke Cerebrovasc Dis       Date:  2016-04-29       Impact factor: 2.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.